INTEGRA LIFESCIENCES HOLDINGS CORP [IART] has reported a net loss of $67.7 million for year ended Dec 31, 2023.
The Company said in a filing before the Securities and Exchange Commission that its total revenue for the year was $1.5 billion
Based in PRINCETON, New Jersey, INTEGRA LIFESCIENCES HOLDINGS CORP operates in the MANUFACTURING sector.
In the fiscal year ended December 31, 2023, the company reported total revenue of $1.54 billion, showing a slight decrease compared to the total revenue of $1.56 billion in the previous fiscal year ended December 31, 2022, and a slight increase compared to the total revenue of $1.54 billion in the fiscal year ended December 31, 2021.
Cost of goods sold for the fiscal year ended December 31, 2023, amounted to $656.8 million, marking an increase from the cost of goods sold of $587.4 million in the previous fiscal year ended December 31, 2022, and a decrease from the cost of goods sold of $597.8 million in the fiscal year ended December 31, 2021.
Operating income for the fiscal year ended December 31, 2023, was $111.5 million, showing a significant decrease compared to the operating income of $238.9 million in the previous fiscal year ended December 31, 2022, and an increase compared to the operating income of $197.2 million in the fiscal year ended December 31, 2021.
The net income for the fiscal year ended December 31, 2023, was $67.7 million, indicating a decline from the net income of $180.6 million in the previous fiscal year ended December 31, 2022, and an increase from the net income of $169.1 million in the fiscal year ended December 31, 2021.
Earnings per share, both basic and diluted, for the fiscal year ended December 31, 2023, were $0.85 and $0.84, respectively. This marks a decrease from the earnings per share of $2.18 and $2.16, respectively, in the previous fiscal year ended December 31, 2022, and from $2.00 and $1.98, respectively, in the fiscal year ended December 31, 2021.
Also Read: